NDC 59137-231

GLEOLAN

Aminolevulinic Acid Hydrochloride

GLEOLAN is a Oral Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Medexus Pharma, Inc.. The primary component is Aminolevulinic Acid Hydrochloride.

Product ID59137-231_1e70e08b-337c-42d5-9b37-5c8f6fbcce7e
NDC59137-231
Product TypeHuman Prescription Drug
Proprietary NameGLEOLAN
Generic NameAminolevulinic Acid Hydrochloride
Dosage FormPowder, For Solution
Route of AdministrationORAL
Marketing Start Date2018-04-14
Marketing CategoryNDA /
Application NumberNDA208630
Labeler NameMedexus Pharma, Inc.
Substance NameAMINOLEVULINIC ACID HYDROCHLORIDE
Active Ingredient Strength1500 mg/1
Pharm ClassesFluorescence Contrast Activity [MoA], Optical Imaging Agent [EPC], Porphyrin Precursor [EPC], Porphyrinogens [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 59137-231-01

1 VIAL, SINGLE-DOSE in 1 CARTON (59137-231-01) > 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
Marketing Start Date2022-03-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "GLEOLAN" or generic name "Aminolevulinic Acid Hydrochloride"

NDCBrand NameGeneric Name
59137-231GLEOLANAMINOLEVULINIC ACID HYDROCHLORIDE
71469-231GLEOLANAMINOLEVULINIC ACID HYDROCHLORIDE
70621-101AMELUZaminolevulinic acid hydrochloride
67308-101LEVULAN KERASTICKaminolevulinic acid hydrochloride

Trademark Results [GLEOLAN]

Mark Image

Registration | Serial
Company
Trademark
Application Date
GLEOLAN
GLEOLAN
87925599 5852682 Live/Registered
photonamic GmbH & Co. KG
2018-05-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.